Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II/III Study of JR-141 in Patients With Mucopolysaccharidosis II

Next Previous
Trial Profile

A Phase II/III Study of JR-141 in Patients With Mucopolysaccharidosis II

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Jan 2019

At a glance

  • Drugs Idursulfase (Primary)
  • Indications Mucopolysaccharidosis II
  • Focus Therapeutic Use
  • Sponsors JCR Pharmaceuticals

    • Most Recent Events

    • 28 Dec 2018 Status changed from recruiting to active, no longer recruiting, according to a JCR Pharmaceuticals media release.
    • 09 Aug 2018 Status changed from not yet recruiting to recruiting, according to a JCR Pharmaceuticals media release.
    • 13 Jun 2018 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top